Luminex Corporation Receives FDA Clearance for ARIES Group A Strep Assay
AUSTIN, Texas, Oct. 31, 2017 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that it has received FDA clearance for the ARIES® Group A Strep Assay, a moderate complexity, sample to answer test for the direct detection of Streptococcus pyogenes from throat swab specimens using the ARIES® System. This is the sixth assay the FDA has... Read more